![Adrienne Farid](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Adrienne Farid
No open positions remaining
Net worth: 612 845 $ as of 30/05/2026
Profile
Adrienne Farid worked at Roche Pharmaceuticals, Inc. from 1995 to 2011 as Global Head-Project & Portfolio Management.
From 2014 to 2017, worked at Celgene Corp.
as VP-Project Leadership.
Served as Director at Carisma Therapeutics, Inc. Worked at Century Therapeutics, Inc. from 2021 to 2025 as Chief Development Officer & Head-Early Development from 2024 to 2025.
Education includes a doctorate from The Trustees of Columbia University in The City of New York and an undergraduate degree from Barnard College.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 30/03/2026 | 250,141 ( 0.14% ) | 612 845 $ | 30/05/2026 |
Former positions of Adrienne Farid
| Companies | Position | End |
|---|---|---|
| CENTURY THERAPEUTICS, INC. | Chief Operating Officer | 30/09/2024 |
| CELGENE | Corporate Officer/Principal | 30/06/2017 |
Roche Pharmaceuticals, Inc.
 Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development services | Corporate Officer/Principal | 31/12/2010 |
| CARISMA THERAPEUTICS, INC. | Director/Board Member | - |
Training of Adrienne Farid
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
42
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Roche Pharmaceuticals, Inc.
Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development services | Commercial Services |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Barnard College
 Barnard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Century Therapeutics, Inc.
 Century Therapeutics, Inc. BiotechnologyHealth Technology Develops novel allogeneic living drugs for oncology that overcome the limitations of first-generation cell therapies | Health Technology |
Carisma Therapeutics, Inc.
 Carisma Therapeutics, Inc. BiotechnologyHealth Technology Develops novel chimeric antigen receptor macrophage and CAR-monocyte technology treatment of non-muscle invasive bladder cancer | Health Technology |
- Stock Market
- Insiders
- Adrienne Farid
